Claret Asset Management Corp Has $590,000 Holdings in Varex Imaging Co. (NASDAQ:VREX)

Claret Asset Management Corp lowered its position in shares of Varex Imaging Co. (NASDAQ:VREX) by 12.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 40,444 shares of the company’s stock after selling 5,560 shares during the quarter. Claret Asset Management Corp’s holdings in Varex Imaging were worth $590,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Canada Pension Plan Investment Board boosted its stake in Varex Imaging by 19.4% during the fourth quarter. Canada Pension Plan Investment Board now owns 11,700 shares of the company’s stock worth $171,000 after acquiring an additional 1,900 shares in the last quarter. Marshall Wace LLP bought a new stake in Varex Imaging in the 4th quarter valued at about $224,000. Barclays PLC raised its stake in Varex Imaging by 1.1% during the 4th quarter. Barclays PLC now owns 98,964 shares of the company’s stock worth $1,444,000 after buying an additional 1,081 shares during the period. LSV Asset Management boosted its holdings in Varex Imaging by 826.3% in the fourth quarter. LSV Asset Management now owns 326,979 shares of the company’s stock worth $4,771,000 after acquiring an additional 291,679 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in Varex Imaging by 9.6% in the fourth quarter. Renaissance Technologies LLC now owns 259,700 shares of the company’s stock valued at $3,789,000 after acquiring an additional 22,800 shares during the period.

Varex Imaging Price Performance

VREX opened at $7.32 on Friday. The company has a debt-to-equity ratio of 1.02, a current ratio of 4.36 and a quick ratio of 2.50. The firm’s fifty day moving average price is $11.35 and its two-hundred day moving average price is $13.08. Varex Imaging Co. has a 1 year low of $7.11 and a 1 year high of $17.46. The company has a market capitalization of $301.58 million, a price-to-earnings ratio of -6.26 and a beta of 0.65.

Varex Imaging (NASDAQ:VREX) last posted its earnings results on Thursday, February 6th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.04 by $0.03. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. As a group, analysts anticipate that Varex Imaging Co. will post 0.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on VREX shares. Oppenheimer cut their target price on Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a report on Friday, February 7th. StockNews.com upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a report on Friday, February 7th. Finally, B. Riley reiterated a “buy” rating and set a $22.00 price target (up previously from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th.

Insider Transactions at Varex Imaging

In other Varex Imaging news, CEO Sunny Sanyal sold 8,749 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total value of $98,338.76. Following the sale, the chief executive officer now directly owns 190,193 shares in the company, valued at $2,137,769.32. This represents a 4.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Kimberley E. Honeysett sold 4,007 shares of Varex Imaging stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total value of $51,329.67. Following the sale, the senior vice president now directly owns 4,002 shares of the company’s stock, valued at $51,265.62. This represents a 50.03 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company’s stock.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.